NK T cells contribute to expansion of CD8+ T cells and amplification of antiviral immune responses to respiratory syncytial virus

Journal of Virology

Volumn 76, Issue 9, 2002, Pages 4294-4303

  Johnson, Teresa R ^a   Hong, Seokmann ^a   Van Kaer, Luc ^a   Koezuka, Yasuhiko ^a   Graham, Barney S ^a  

^a NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD1 ANTIGEN; FORMALDEHYDE; GAMMA INTERFERON; IMMUNOLOGICAL ADJUVANT; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; THROMBOSPONDIN; VIRUS GLYCOPROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; EOSINOPHILIA; HUMAN; HUMAN CELL; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOMODULATION; IMMUNOPATHOGENESIS; MOUSE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; RESPIRATORY SYNCYTIAL PNEUMOVIRUS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; VIRUS IMMUNITY;

ANIMALS; ANTIGEN PRESENTATION; ANTIGENS, CD1; GALACTOSYLCERAMIDES; IMMUNIZATION; KILLER CELLS, NATURAL; LIGANDS; LYMPHOCYTE ACTIVATION; MICE; MICE, INBRED BALB C; MICE, INBRED C57BL; RESPIRATORY SYNCYTIAL VIRUS INFECTIONS; RESPIRATORY SYNCYTIAL VIRUS VACCINES; RESPIRATORY SYNCYTIAL VIRUSES; T-LYMPHOCYTES, CYTOTOXIC; VIRAL PROTEINS;

EID: 0036223536     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/JVI.76.9.4294-4303.2002     Document Type: Article

References (86)

1. Distinct types of lung disease caused by functional subsets of antiviral T cells
2. Analysis of the local and systemic immune responses induced in BALB/c mice by experimental respiratory syncytial virus infection
3. Cytokine response to respiratory syncytial virus stimulation of human peripheral blood mononuclear cells
4. Biological effects of recombinant vaccinia virus-expressed interleukin-4
5. Murine natural killer T (NKT) cells [correction of natural killer cells] contribute to the granulomatous reaction caused by mycobacterial cell walls
6. + T respiratory syncytial virus-specific cytotoxic T-lymphocyte activity in vivo
7. IL-4 diminishes perforin-mediated and increases Fas ligand-mediated cytotoxicity in vivo
8. Recombinant vaccinia virus coexpressing the F protein of respiratory syncytial virus (RSV) and interleukin-4 (IL-4) does not inhibit the development of RSV-specific memory cytotoxic T lymphocytes, whereas priming is diminished in the presence of high levels of IL-2 or gamma interferon
9. Mouse CD1-specific NK1 T cells. Development, specificity, and function
10. NK cell modulation of murine cytomegalovirus retinitis
11. Initial and innate responses to viral infections-pattern setting in immunity or disease
12. NK and NKT cells in innate defense against viral infections
13. Comparison of the T helper cell response induced by respiratory syncytial virus and its fusion protein in BALB/c mice
14. Major histocompatibility complex class I antigens and the control of viral infections by natural killer cells
15. Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis
16. + NK T lymphocytes
17. Cytotoxic T cells clear virus but augment lung pathology in mice infected with respiratory syncytial virus
18. Two roads diverged: Interferon α/β- and interleukin 12-mediated pathways in promoting T cell interferon γ responses during viral infection
19. + effector function against intracellular infection
20. A role for IFN-α/β in virus infection-induced sensitization to endotoxin
21. Respiratory syncytial virus is an important cause of community-acquired lower respiratory infection among hospitalized adults
22. Selective induction of NK cell proliferation and cytotoxicity by activated NKT cells
23. + TCR alpha/beta intermediate liver lymphocytes are down-regulated by Listeria monocytogenes
24. Transient control of interleukin4-producing natural killer T cells in the livers of Listeria monocytogenesinfected mice by interleukin-12
25. CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus
26. Serologic evidence of respiratory syncytial virus infection in nursing home patients
27. Overexpression of interleukin-4 delays virus clearance in mice infected with respiratory syncytial virus
28. Obligatory role of IFN-γ in induction of lymphokine-activated and T lymphocyte killer activity, but not in boosting of natural cytotoxicity
29. Role of T lymphocyte subsets in the pathogenesis of primary infection and rechallenge with respiratory syncytial virus in mice
30. Priming immunization determines T helper cytokine mRNA expression patterns in lungs of mice challenged with respiratory syncytial virus
31. Immunological determinants of disease caused by respiratory syncytial virus
32. Primary respiratory syncytial virus infection in mice
33. Murine CD1d-restricted T cell recognition of cellular lipids
34. Characteristics of the pulmonary natural killer (NK) cell response to respiratory syncytial virus infection in BALB/c mice
35. The natural killer T-cell ligand α-galacatosylceramide prevents autoimmune diabetes in non-obese diabetic mice
36. The genome of respiratory syncytial virus is a negative-stranded RNA that codes for at least seven mRNA species
37. + T cells control Th2-driven pathology during pulmonary respiratory syncytial virus infection
38. IL-12 treatment attenuates T helper cell type 2 and B cell responses but does not improve vaccine-enhanced lung illness
39. + T cell recruitment during respiratory syncytial virus infection
40. h cell lines following stimulation with RS virus and RS virus proteins
41. Secreted respiratory syncytial virus G glycoprotein induces interleukin-5 (IL-5), IL-13, and eosinophilia by an IL-4-independent mechanism
42. Priming with secreted glycoprotein G of respiratory syncytial virus (RSV) augments interleukin-5 production and tissue eosinophilia after RSV challenge
43. Natural ligand of mouse CD1d1: Cellular glycosylphosphatidylinositol
44. Natural killer T cell activation inhibits hepatitis B virus replication in vivo
45. An epidemiologic study of altered clinical reactivity to respiratory syncytial (RS) virus infection in children previously vaccinated with an inactivated RS virus vaccine
46. α14 NKT cells by glycosylceramides
47. Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine
48. Cytotoxic T cells specific for a single peptide on the M2 protein of respiratory syncytial virus are the sole mediators of resistance induced by immunization with M2 encoded by a recombinant vaccinia virus
49. CD1d deficiency impairs murine host defense against the spirochete Borrelia burgdorferi
50. Primary pulmonary cytotoxic T lymphocytes induced by immunization with a vaccinia virus recombinant expressing influenza A virus nucleoprotein peptide do not protect mice against challenge
51. IL-4-producing NK T cells are biased towards IFN-gamma production by IL-12. Influence of the microenvironment on the functional capacities of NK T cells
52. Influence of a psychogenic and a neurogenic stressor on several indices of immune functioning in different strains of mice
53. Natural killer activating receptors trigger interferon gamma secretion from T cells and natural killer cells
54. Asthma and wheezing in the first six years of life
55. Bronchiolitis and asthma: Possible common pathogenetic pathways
56. CD1d1 mutant mice are deficient in natural T cells that promptly produce IL-4
57. Counting antigen-specific CD8 T cells: A reevaluation of bystander activation during viral infection
58. Adjuvants influence the quantitative and qualitative immune response in BALB/c mice immunized with respiratory syncytial virus FG subunit vaccine
59. Cytokine release and innate immunity in respiratory viral infection
60. Interferon α/β-mediated inhibition and promotion of interferon γ: STAT1 resolves a paradox
61. The interface between innate and acquired immunity: Glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes
62. Presence of respiratory syncytial virus genomic sequences in middle ear fluid and its relationship to expression of cytokines and cell adhesion molecules
63. Selective IL-18 requirements for induction of compartmental IFN-γ responses during viral infection
64. The CD1 system: Antigen-presenting molecules for T cell recognition of lipids and glycolipids
65. Alternative mechanisms of respiratory syncytial virus clearance in perforin knockout mice lead to enhanced disease
66. NK cell trafficking and cytokine expression in splenic compartments after IFN induction and viral infection
67. CD1d-restricted immunoglobulin T formation to GPI-anchored antigens mediated by NKT cells
68. Norepinephrine and serotonin alterations following chronic stressor exposure: Mouse strain differences
69. Interleukin-4 mediates down regulation of antiviral cytokine expression and cytotoxic T-lymphocyte responses and exacerbates vaccinia virus infection in vivo
70. Bronchiolitis-associated hospitalizations among US children, 1980-1986
71. Activation of NK T cells by CD1d and α-galactosylceramide directs conventional T cells to the acquisition of a Th2 phenotype
72. Abundant IFN-γ production by local T cells in respiratory syncytial virus-induced eosinophilic lung disease
73. Induction of Th-1 and Th-2 responses by respiratory syncytial virus attachment glycoprotein is epitope and major histocompatibility complex independent
74. + T lymphocytes down regulate Th2 type cytokine secretion and pulmonary eosinophilia during experimental murine respiratory syncytial virus infection
75. Virus-specific memory and effector T lymphocytes exhibit different cytokine responses to antigens during experimental murine respiratory syncytial virus infection
76. NK cell functions restrain T cell responses during viral infections
77. Anti-IL-4 treatment at immunization modulates cytokine expression, reduces illness, and increases cytotoxic T lymphocyte activity in mice challenged with respiratory syncytial virus
78. Determinants and kinetics of cytokine expression patterns in lungs of vaccinated mice challenged with respiratory syncytial virus
79. T cell source of type 1 cytokines determines illness patterns in respiratory syncytial virus-infected mice
80. Interleukin-12 treatment during immunization elicits a T helper cell type 1-like immune response in mice challenged with respiratory syncytial virus and improves vaccine immunogenicity
81. 2-microglobulin-deficient mice
82. Atypical pulmonary eosinophilia is mediated by a specific amino acid sequence of the attachment (G) protein of respiratory syncytial virus
83. Combination therapy with aerosolized ribavirin and intravenous immunoglobulin for respiratory syncytial virus disease in adult bone marrow transplant recipients
84. Community respiratory virus infections among hospitalized adult bone marrow transplant recipients
85. Strain differences in natural killer cell-mediated immunity among mice: A possible mechanism for the low natural killer cell activity of A/J mice
86. H2 response and in immunoglobulin E production